Nautilus Biotechnology to Participate in the Investor Summit Group Virtual Conference

Rhea-AI Summary

Nautilus Biotechnology (NASDAQ: NAUT) will participate in the Investor Summit Group Virtual Conference. Management is scheduled to present on Wednesday, March 25, 2026 at 10:00 a.m. PT / 1:00 p.m. ET. Live and archived webcasts will be available in the Investors section of the company website.

Investors can access the webcast at www.nautilus.bio.

News Market Reaction – NAUT

+9.12% 3.0x vol

9 alerts

+9.12% News Effect

+12.5% Peak in 27 hr 7 min

+$46M Valuation Impact

$545.51M Market Cap

3.0x Rel. Volume

On the day this news was published, NAUT gained 9.12%, reflecting a notable positive market reaction. Argus tracked a peak move of +12.5% during that session. Our momentum scanner triggered 9 alerts that day, indicating moderate trading interest and price volatility. This price movement added approximately $46M to the company's valuation, bringing the market cap to $545.51M at that time. Trading volume was very high at 3.0x the daily average, suggesting strong buying interest.

Data tracked by StockTitan Argus on the day of publication.

Key Figures

Conference date: March 25, 2026 Presentation time PT: 10:00 a.m. Pacific Time Presentation time ET: 1:00 p.m. Eastern Time

3 metrics

Conference date March 25, 2026 Investor Summit Group Virtual Conference presentation date

Presentation time PT 10:00 a.m. Pacific Time Scheduled Nautilus management presentation slot

Presentation time ET 1:00 p.m. Eastern Time Scheduled Nautilus management presentation slot

Market Reality Check

Price: $3.48 Vol: Volume 1,079,403 is 4.07x...

high vol

$3.48 Last Close

Volume Volume 1,079,403 is 4.07x the 20-day average of 265,260, indicating elevated trading activity before this conference update. high

Technical Price at 3.62 is trading above the 200-day MA of 1.46 and sits 3.46% below the 52-week high of 3.7499.

Peers on Argus

NAUT is up 19.47% while momentum scanner shows peer QNCX moving -6.50% with no n...

1 Down

NAUT is up 19.47% while momentum scanner shows peer QNCX moving -6.50% with no news; broader peers show mixed moves, suggesting today’s strength is stock-specific rather than a coordinated sector move.

Historical Context

5 past events · Latest: Mar 18 (Positive)

Pattern 5 events

Date	Event	Sentiment	Move	Catalyst
Mar 18	Early Access customer	Positive	+3.4%	Baylor College of Medicine named first Early Access customer for Voyager platform.
Mar 02	Leadership hire	Positive	-4.1%	Appointment of proteomics commercial leader as VP of Sales for Voyager launch.
Feb 26	Earnings results	Negative	-16.3%	Q4 and FY2025 results with significant operating expenses and net loss disclosed.
Feb 24	Platform unveil	Positive	+5.2%	Voyager platform unveiled with high-throughput Iterative Mapping and Tau assay data.
Feb 19	Conference participation	Neutral	-2.4%	Announcement of participation in TD Cowen health care conference with fireside chat.

Pattern Detected

NAUT has often reacted positively to product/platform milestones, while earnings and personnel changes have seen more mixed or negative reactions.

Recent Company History

Over the past months, Nautilus has focused on launching its Voyager™ single-molecule proteomics platform and building commercial readiness. Key events included the Voyager unveil and Early Access Program in Feb 2026, followed by Baylor College of Medicine joining as the first Early Access customer on Mar 18, 2026. Financial results on Feb 26, 2026 highlighted ongoing losses and rising operating expenses. The current Investor Summit conference appearance fits a pattern of active investor and scientific outreach alongside platform commercialization efforts.

Market Pulse Summary

The stock moved +9.1% in the session following this news. A strong positive reaction aligns with NAU...

Analysis

The stock moved +9.1% in the session following this news. A strong positive reaction aligns with NAUT’s history of sizable moves around visibility and platform milestones, even when news is informational, such as conference participation. With the stock up 19.47% on volume 4.07x its 20-day average and trading just below its 52-week high, prior patterns show that enthusiasm has sometimes reversed after earnings or less clearly accretive updates, so investors have often reassessed once excitement cooled.

Key Terms

single-molecule protein analysis platform

1 terms

single-molecule protein analysis platform medical

"a company pioneering a single-molecule protein analysis platform, today announced"

A single-molecule protein analysis platform is a laboratory technology that detects and measures individual protein molecules rather than averaging many at once, like counting each person in a crowd instead of estimating crowd size. For investors, it matters because that higher sensitivity and precision can enable earlier disease detection, more accurate diagnostics and tighter drug development control, potentially creating faster paths to market and stronger competitive advantage in biotech and diagnostics markets.

AI-generated analysis. Not financial advice.

SEATTLE, March 24, 2026 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering a single-molecule protein analysis platform, today announced the company will be participating in the Investor Summit Group Virtual Conference.

Nautilus’ management is scheduled to present on Wednesday, March 25, 2026, at 10:00 a.m. Pacific Time / 1:00 p.m. Eastern Time. Interested parties may access live and archived webcasts of the presentations on the “Investors” section of the company website at: www.nautilus.bio.

About Nautilus Biotechnology, Inc.
With its corporate headquarters in Seattle, Washington and its research and development headquarters in San Carlos, California, Nautilus is a development stage life sciences company working to create a platform technology for quantifying and unlocking the complexity of the proteome. Nautilus’ mission is to transform the field of proteomics by democratizing access to the proteome and enabling fundamental advancements across human health and medicine. To learn more about Nautilus, visit www.nautilus.bio.

Media Contact
press@nautilus.bio

Investor Contact
investorrelations@nautilus.bio

FAQ

When will Nautilus (NAUT) present at the Investor Summit Group Virtual Conference?

Nautilus will present on Wednesday, March 25, 2026 at 10:00 a.m. PT / 1:00 p.m. ET. According to Nautilus, the management presentation will be webcast live and archived for later viewing on the company investor website.

How can I watch the Nautilus (NAUT) Investor Summit Group presentation on March 25, 2026?

You can watch the presentation via live webcast and archived replay on the company investor site. According to Nautilus, both live and archived webcasts will be available in the "Investors" section at www.nautilus.bio for public access.

Will Nautilus (NAUT) make the Investor Summit Group presentation available after the live event?

Yes, Nautilus will provide an archived webcast after the live presentation for on-demand viewing. According to Nautilus, the archived replay will be posted in the Investors section of the company website for interested parties.

What time should investors tune in for the Nautilus (NAUT) presentation on March 25, 2026?

Investors should tune in at 10:00 a.m. PT / 1:00 p.m. ET on March 25, 2026 for the live presentation. According to Nautilus, management is scheduled to present at that specific time and the session will be webcast live.

Where on the Nautilus (NAUT) website will the Investor Summit webcast be hosted?

The webcast will be hosted in the "Investors" section of the Nautilus website at www.nautilus.bio. According to Nautilus, both live and archived presentations related to the Investor Summit Group virtual conference will be available there.

Is the Nautilus (NAUT) Investor Summit presentation open to the public on March 25, 2026?

Yes, the presentation is accessible via public webcast through the company investor site. According to Nautilus, interested parties may access the live webcast and archived replay on the Investors page at www.nautilus.bio.